Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric Population with Hereditary Hemorrhagic Telangiectasias—A Retrospective Case Series
Embolotherapy of pAVMs in pediatric patients with HHT was safe, with a high rate of persistence when coils were predominantly used. The risk of primary persistence was associated with age less than 15 years and the use of larger diameter plugs/coils.
Authors
- Emily C. Bendel (ORCID: https://orcid.org/0000-0002-6467-8641)
- Nadir Demirel (ORCID: https://orcid.org/0000-0001-6358-1728)
- Haraldur Bjarnason (ORCID: https://orcid.org/0000-0003-0448-9168)
- Sanjay Misra (ORCID: https://orcid.org/0000-0001-5662-796X)
- Vivek Iyer (ORCID: https://orcid.org/0000-0001-6441-9319)
- Haseeb Mukhtar (ORCID: https://orcid.org/0000-0002-1433-4058)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of Vascular and Interventional Radiology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.jvir.2025.01.047
- Citations
- 2
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.25